Projects per year
Fingerprint
Dive into the research topics where Sofie Deschoemaeker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
FWOSB136: Towards the rational design of cancer therapies combining tumorderived dendritic cell vaccinations with regulatory T
Laoui, D., Deschoemaeker, S. & Bravo Melgar, J.
1/11/22 → 31/10/26
Project: Fundamental
-
Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity
Hamouda, A. E. I., Filtjens, J., Brabants, E., Kancheva, D., Debraekeleer, A., Brughmans, J., Jacobs, L., Bardet, P. M. R., Knetemann, E., Lefesvre, P., Allonsius, L., Gontsarik, M., Varela, I., Crabbé, M., Clappaert, E. J., Cappellesso, F., Caro, A. A., Peiró, A. G., Fredericq, L., Hadadi, E. & 9 others, , 6 Dec 2024, In: Nature communications. 20 p., 10635.Research output: Contribution to journal › Article › peer-review
-
Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models
Clappaert, E., Kancheva, D., Debraekeleer, A., Brughmans, J., Bardet, P., Elkrim, Y., Lacroix, D., Zivalj, M., Hamouda, A. E. I., Van Ginderachter, J., Deschoemaeker, S. & Laoui, D., 16 Oct 2023.Research output: Unpublished contribution to conference › Poster
-
Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models
Clappaert, E. J., Kancheva, D., Brughmans, J., Debraekeleer, A., Bardet, P. M. R., Elkrim, Y., Lacroix, D., Živalj, M., Hamouda, A. E. I., Van Ginderachter, J. A., Deschoemaeker, S. & Laoui, D., 2023, In: Frontiers in Immunology. 14, 11 p., 1166180.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)25 Downloads (Pure) -
CCR8 as novel target for tumor-infiltrating Tregs in triple negative breast cancer
Deschoemaeker, S., 16 Jun 2022.Research output: Unpublished contribution to conference › Poster
-
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
Verheye, E., Melgar, J. B., Deschoemaeker, S., Raes, G., Maes, A., De Bruyne, E., Menu, E., Vanderkerken, K., Laoui, D. & De Veirman, K., 14 Jan 2022, In: International Journal of Molecular Sciences. 23, 2, 904.Research output: Contribution to journal › Scientific review › peer-review
Open Access32 Citations (Scopus)
-
Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models
Emile Clappaert (Speaker), Daliya Kancheva (Contributor), Jan Brughmans (Contributor), Ayla Debraekeleer (Contributor), Pauline Bardet (Contributor), Yvon Elkrim (Contributor), Dagmar Lacroix (Contributor), Maida Zivalj (Contributor), Ahmed Emad Ibrahim Hamouda (Contributor), Jo Van Ginderachter (Contributor), Sofie Deschoemaeker (Contributor) & Damya Laoui (Contributor)
16 Oct 2023Activity: Talk or presentation › Talk or presentation at a conference
-
Flt3L therapy induces a Treg-promoting cDC1 state in triple-negative breast cancer
Emile Clappaert (Speaker), Daliya Kancheva (Contributor), Jan Brughmans (Contributor), Ayla Debraekeleer (Contributor), Pauline Bardet (Contributor), Yvon Elkrim (Contributor), Dagmar Lacroix (Contributor), Maida Zivalj (Contributor), Ahmed Emad Ibrahim Hamouda (Contributor), Jo Van Ginderachter (Contributor), Sofie Deschoemaeker (Contributor) & Damya Laoui (Contributor)
8 Jun 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
CCR8 as novel target for tumor-infiltrating Tregs in triple negative breast cancer
Sofie Deschoemaeker (Speaker)
27 Sep 2022Activity: Talk or presentation › Talk or presentation at a conference